Multisite Left Ventricular Pacing in Cardiac Resynchronization Therapy

References

1. • Tracy C.M.
   • Epstein A.E.
   • Darbar D.
   • et al.
   2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities.
   J Am Coll Cardiol. 2013; 61https://doi.org/10.1016/j.jacc.2012.11.007
   View in Article

   • Google Scholar
2. • Bristow M.R.
   • Saxon L.A.
   • Boehmer J.
   • et al.
   Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
   N Engl J Med. 2004; 350: 2140-2150
   View in Article

   • Google Scholar
3. • Cleland J.G.F.
   • Daubert J.-C.
   • Erdmann E.
   • et al.
   The effect of cardiac resynchronization on morbidity and mortality in heart failure.
   N Engl J Med. 2005; 352: 1539-1549
   View in Article

   • Google Scholar
4. • Moss A.J.
   • Hall W.J.
   • Cannom D.S.
   • et al.
   Cardiac-resynchronization therapy for the prevention of heart-failure events.
   N Engl J Med. 2009; 361: 1329-1338
   View in Article

   • Google Scholar
5. • Young J.B.
   • Abraham W.T.
   • Smith A.L.
   • et al.
   Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
   JAMA. 2003; 289: 2685-2694
   View in Article

   • Google Scholar
6. • Tanaka H.
   • Hara H.
   • Saba S.
   • et al.
   Prediction of response to cardiac resynchronization therapy by speckle tracking echocardiography using different software approaches.
   J Am Soc Echocardiogr. 2009; 22: 677-684
   View in Article

   • Google Scholar
7. • Tanaka H.
   • Nesser H.-J.
   • Buck T.
   • et al.
   Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Resynchronization (STAR) study.
   Eur Heart J. 2010; 31: 1690-1700
   View in Article

   • Google Scholar
8. • Adelstein E.C.
   • Saba S.
   Baseline scintigraphic abnormalities by myocardial perfusion imaging predict echocardiographic response to cardiac resynchronization therapy in nonischemic cardiomyopathy.
   Clin Cardiol. 2008; 31: 217-224
   View in Article

   • Google Scholar
9. • Varma N.
   • Auricchio A.
   • Connolly A.T.
   • et al.
   The cost of non-response to cardiac resynchronization therapy: characterizing heart failure events following cardiac resynchronization therapy.
   Europace. 2021; 00: 1-10
   View in Article

   • Google Scholar
10. • Bertini M.
    • Höke U.
    • van Bommel R.J.
    • et al.
    Impact of clinical and echocardiographic response to cardiac resynchronization therapy on long-term survival.
    Eur Heart J Cardiovasc Imaging. 2013; 14https://doi.org/10.1093/ehjci/jes290
    View in Article

    • Google Scholar
11. • Gold M.R.
    • Thébault C.
    • Linde C.
    • et al.
    Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE) study.
    Circulation. 2012; 126https://doi.org/10.1161/CIRCULATIONAHA.112.097709
    View in Article

    • Google Scholar
12. • Abraham W.T.
    • Fisher W.G.
    • Smith A.L.
    • et al.
    Cardiac resynchronization in chronic heart failure.
    N Engl J Med. 2002; 346: 1845-1853
    View in Article

    • Google Scholar
13. • Rickard J.
    • Bassiouny M.
    • Cronin E.M.
    • et al.
    Predictors of response to cardiac resynchronization therapy in patients with a non-left bundle branch block morphology.
    Am J Cardiol. 2011; 108https://doi.org/10.1016/j.amjcard.2011.07.017
    View in Article

    • Google Scholar
14. • Saba S.
    • Marek J.
    • Alam M.B.
    • et al.
    Influence of QRS duration on outcome of death or appropriate defibrillator therapy by strategy of left ventricular lead placement in cardiac resynchronization therapy recipients.
    J Interv Card Electrophysiol. 2014; 41: 211-215
    View in Article

    • Google Scholar
15. • Barsheshet A.
    • Goldenberg I.
    • Moss A.J.
    • et al.
    Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT.
    Eur Heart J. 2011; 32https://doi.org/10.1093/eurheartj/ehq407
    View in Article

    • Google Scholar
16. • Daya H.A.
    • Alam M.B.
    • Adelstein E.
    • et al.
    Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy in ischemic vs nonischemic cardiomyopathy patients.
    Hear Rhythm. 2014; 11https://doi.org/10.1016/j.hrthm.2014.01.023
    View in Article

    • Google Scholar
17. • Adelstein E.C.
    • Tanaka H.
    • Soman P.
    • et al.
    Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy.
    Eur Heart J. 2011; 32: 93-103
    View in Article

    • Google Scholar
18. • Beela A.S.
    • Duchenne J.
    • Petrescu A.
    • et al.
    Sex-specific difference in outcome after cardiac resynchronization therapy.
    Eur Heart J Cardiovasc Imaging. 2019; 20https://doi.org/10.1093/ehjci/jey231
    View in Article

    • Google Scholar
19. • Herz N.D.
    • Engeda J.
    • Zusterzeel R.
    • et al.
    Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events.
    J Womens Health. 2015; 24https://doi.org/10.1089/jwh.2014.4980
    View in Article

    • Google Scholar
20. • Varma N.
    • Lappe J.
    • He J.
    • et al.
    Sex-Specific response to cardiac resynchronization therapy: effect of left ventricular size and QRS duration in left bundle branch block.
    JACC Clin Electrophysiol. 2017; 3https://doi.org/10.1016/j.jacep.2017.02.021
    View in Article

    • Google Scholar
21. • Khan F.Z.
    • Virdee M.S.
    • Palmer C.R.
    • et al.
    Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
    J Am Coll Cardiol. 2012; 59https://doi.org/10.1016/j.jacc.2011.12.030
    View in Article

    • Google Scholar
22. • Saba S.
    • Marek J.
    • Schwartzman D.
    • et al.
    Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking assisted resynchronization therapy for electrode region trial.
    Circ Heart Fail. 2013; 6: 427-434
    View in Article

    • Google Scholar
23. • Marek J.J.
    • Saba S.
    • Onishi T.
    • et al.
    Usefulness of echocardiographically guided left ventricular lead placement for cardiac resynchronization therapy in patients with intermediate QRS width and non-left bundle branch block morphology.
    Am J Cardiol. 2014; 113: 107-116
    View in Article

    • Google Scholar
24. • Gold M.R.
    • Birgersdotter-Green U.
    • Singh J.P.
    • et al.
    The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy.
    Eur Heart J. 2011; 32https://doi.org/10.1093/eurheartj/ehr329
    View in Article

    • Google Scholar
25. • Cazeau S.
    • Ritter P.
    • Lazarus A.
    • et al.
    Multisite pacing for end-stage heart failure: early experience.
    Pacing Clin Electrophysiol. 1996; 19https://doi.org/10.1111/j.1540-8159.1996.tb03218.x
    View in Article

    • Google Scholar
26. • Cazeau S.
    • Leclercq C.
    • Lavergne T.
    • et al.
    Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.
    N Engl J Med. 2001; 344: 873-880
    View in Article

    • Google Scholar
27. • Sohal M.
    • Shetty A.
    • Niederer S.
    • et al.
    Mechanistic insights into the benefits of multisite pacing in cardiac resynchronization therapy: the importance of electrical substrate and rate of left ventricular activation.
    Hear Rhythm. 2015; 12https://doi.org/10.1016/j.hrthm.2015.07.012
    View in Article

    • Google Scholar
28. • Thibault B.
    • Dubuc M.
    • Khairy P.
    • et al.
    Acute haemodynamic comparison of multisite and biventricular pacing with a quadripolar left ventricular lead.
    Europace. 2013; 15https://doi.org/10.1093/europace/eus435
    View in Article

    • Google Scholar
29. • Netzler P.
    • Cuoco F.
    • George A.
    • et al.
    The effect of left ventricular sensing electrode position on electrical delay in cardiac resynchronization therapy.
    J Am Coll Cardiol. 2014; 63https://doi.org/10.1016/s0735-1097(14)60448-4
    View in Article

    • Google Scholar
30. • Heckman L.I.B.
    • Kuiper M.
    • Anselme F.
    • et al.
    Evaluating multisite pacing strategies in cardiac resynchronization therapy in the preclinical setting.
    Hear Rhythm O2. 2020; 1https://doi.org/10.1016/j.hroo.2020.03.003
    View in Article

    • Google Scholar
31. • Siciliano M.
    • Migliore F.
    • Badano L.
    • et al.
    Cardiac resynchronization therapy by multipoint pacing improves response of left ventricular mechanics and fluid dynamics: a three-dimensional and particle image velocimetry echo study.
    Europace. 2017; 19https://doi.org/10.1093/europace/euw331
    View in Article

    • Google Scholar
32. • Osca J.
    • Alonso P.
    • Cano O.
    • et al.
    The use of multisite left ventricular pacing via quadripolar lead improves acute haemodynamics and mechanical dyssynchrony assessed by radial strain speckle tracking: initial results.
    Europace. 2016; 18https://doi.org/10.1093/europace/euv211
    View in Article

    • Google Scholar
33. • Zanon F.
    • Marcantoni L.
    • Baracca E.
    • et al.
    Hemodynamic comparison of different multisites and multipoint pacing strategies in cardiac resynchronization therapies.
    J Interv Card Electrophysiol. 2018; 53https://doi.org/10.1007/s10840-018-0362-y
    View in Article

    • Google Scholar
34. • Ricciardi D.
    • Giacomo D.G.
    • Antonio B.
    • et al.
    169-04: non invasive hemodynamic optimization of multisite left ventricular pacing: a multicenter pilot study.
    EP Eur. 2016; 18https://doi.org/10.1093/europace/18.suppl_1.i115c
    View in Article

    • Google Scholar
35. • Rinaldi C.A.
    • Leclercq C.
    • Kranig W.
    • et al.
    Improvement in acute contractility and hemodynamics with multipoint pacing via a left ventricular quadripolar pacing lead.
    J Interv Card Electrophysiol. 2014; 40https://doi.org/10.1007/s10840-014-9891-1
    View in Article

    • Google Scholar
36. • Akerström F.
    • Narváez I.
    • Puchol A.
    • et al.
    Estimation of the effects of multipoint pacing on battery longevity in routine clinical practice.
    Europace. 2018; 20https://doi.org/10.1093/europace/eux209
    View in Article

    • Google Scholar
37. • Antoniou K.
    • Chrysohoou C.
    • Dilaveris P.
    • et al.
    Optimization in cardiac resynchronization therapy with quadripolar leads offer improvement in cardiac energetics in heart failure patients compared with bipolar leads: HUMVEE Clinical Trial.
    Eur Heart J. 2020; 41https://doi.org/10.1093/ehjci/ehaa946.0888
    View in Article

    • Google Scholar
38. • Sterliński M.
    • Sokal A.
    • Lenarczyk R.
    • et al.
    In heart failure patients with left bundle branch block single lead multispot left ventricular pacing does not improve acute hemodynamic response to conventional biventricular pacing. A multicenter prospective, interventional, non-randomized study.
    PLoS One. 2016; 11https://doi.org/10.1371/journal.pone.0154024
    View in Article

    • Google Scholar
39. • Niazi I.
    • Baker J.
    • Corbisiero R.
    • et al.
    Safety and efficacy of multipoint pacing in cardiac resynchronization therapy: the MultiPoint pacing trial.
    JACC Clin Electrophysiol. 2017; 3https://doi.org/10.1016/j.jacep.2017.06.022
    View in Article

    • Google Scholar
40. • Leclercq C.
    • Burri H.
    • Curnis A.
    • et al.
    Rationale and design of a randomized clinical trial to assess the safety and efficacy of multipoint pacing therapy: MOre REsponse on cardiac resynchronization therapy with MultiPoint Pacing (MORE-CRT MPP–PHASE II).
    Am Heart J. 2019; 209https://doi.org/10.1016/j.ahj.2018.12.004
    View in Article

    • Google Scholar
41. • Leclercq C.
    • Burri H.
    • Curnis A.
    • et al.
    Cardiac resynchronization therapy non-responder to responder conversion rate in the more response to cardiac resynchronization therapy with MultiPoint Pacing (MORE-CRT MPP) study: results from phase I.
    Eur Heart J. 2019; 40https://doi.org/10.1093/eurheartj/ehz109
    View in Article

    • Google Scholar
42. • Abdelhadi R.
    • Adelstein E.
    • Voigt A.
    • et al.
    Measures of left ventricular dyssynchrony and the correlation to clinical and echocardiographic response after cardiac resynchronization therapy.
    Am J Cardiol. 2008; 102: 598-601
    View in Article

    • Google Scholar

43. Zanon F, Marcantoni L, Baracca E, et al. Optimization of left ventricular pacing site plus multipoint pacing improves remodeling and clinical response to cardiac resynchronization therapy at 1 year. Heart Rhythm. 2016 Aug;13(8):1644–51.

    View in Article

    • Google Scholar

44. Forleo GB, Santini L, Giammaria M, et al. Multipoint pacing via a quadripolar left-ventricular lead: preliminary results from the Italian registry on multipoint left-ventricular pacing in cardiac resynchronization therapy (IRON-MPP). Europace. 2017 Jul 1;19(7):1170–1177.

    View in Article

    • Google Scholar

45. Antoniou CK, Dilaveris P, Chrysohoou C, et al. Multipoint left ventricular pacing effects on hemodynamic parameters and functional status: HUMVEE single-arm clinical trial (NCT03189368). Hellenic J Cardiol. 2021 Mar 4:S1109-9666(21)00049-X. doi:10.1016/j.hjc.2021.02.012.

    View in Article

    • Google Scholar

46. Saba S, Nair D, Ellis CR, et al. Strategic Management to Improve CRT Using Multi-Site Pacing (SMART-MSP) Investigators.Usefulness of Multisite Ventricular Pacing in Nonresponders to Cardiac Resynchronization Therapy. Am J Cardiol. 2022 Feb 1;164:86–92.

    View in Article

    • Google Scholar